Wegovy/Ozempic/Semaglutide are GLP-1 receptor agonists, not GLP-1 antagonists. This means they activate the GLP-1 receptor, which GLP-1 also does. So it’s more accurate to say that they are GLP-1 analogs, which makes calling them “GLP-1s” reasonable even though that’s not really accurate either.
Wegovy/Ozempic/Semaglutide are GLP-1 receptor agonists, not GLP-1 antagonists. This means they activate the GLP-1 receptor, which GLP-1 also does. So it’s more accurate to say that they are GLP-1 analogs, which makes calling them “GLP-1s” reasonable even though that’s not really accurate either.
Yep, whoops, fixing.